Duavee is called Duavive in Europe.
Information about Duavee (Conjugated Estrogens / Bazedoxifene MR)
Duavee is a medication that combines conjugated estrogens with bazedoxifene, designed to address symptoms of menopause and help prevent osteoporosis in postmenopausal women. This combination works by balancing estrogen effects, reducing the risk of endometrial hyperplasia associated with estrogen-only therapy.
Product Highlights
- Indicated for the treatment of moderate to severe vasomotor symptoms (e.g., hot flashes) associated with menopause.
- Used for the prevention of osteoporosis in postmenopausal women at significant risk.
- Contains conjugated estrogens and bazedoxifene to offer both hormonal support and protection against estrogen-related risks.
- Supports bone density and lowers the risk of osteoporosis.
Key Ingredient
- A mixture of estrogen hormones that help alleviate menopausal symptoms.
- A selective estrogen receptor modulator (SERM) that helps protect against estrogen-related side effects, particularly in the uterus.
Key Benefits
- Decreases the occurrence and intensity of hot flashes.
- Decreases the risk of fractures by improving bone density.
- Offers the benefits of estrogen without the associated risks of hyperplasia.
Direction of Use
- Usually recommended as one tablet taken each day.
- Take it with or without food; swallow the tablet whole without chewing.
Safety Concerns
- May include nausea, diarrhea, muscle spasms, and abdominal pain.
- Increased risk of thromboembolic events, cardiovascular issues, and certain cancers; monitor for signs of stroke or deep vein thrombosis.
- Potential for breast tenderness and changes in menstrual bleeding.
Avoid Duavee If
- If you have a history of breast cancer or other cancers sensitive to hormones.
- Avoid if you have a history of thromboembolic disorders or certain cardiovascular conditions.
- Should not be used if you have undiagnosed abnormal vaginal bleeding.
